参考文献/References:
[1] 刘轶蕾 , 苏易 , 吴钰 , 等 . 社区糖尿病高危人群代谢综合征早期防控策略优化研究 [J]. 上海医药 ,2019,40(14): 41-44.LIU Yilei, SU Yi, WU Yu, et al. Study of optimizationof early prevention and control strategies for metabolicsyndrome in high-risk population of diabetes mellitus inthe community[J]. Shanghai Medical & PharmaceuticalJournal,2019,40(14): 41-44.
[2] 龚春雨 , 邓华 , 赖飞 , 等 . 成都地区男性良性前列腺增生率与代谢综合征的相互关系 [J]. 西部医学 ,2019,31(10):1586-1590.GONG Chunyu, DENG Hua, LAI Fei, et al.Preliminary study on the relationship between benignprostatic hyperplasia and metabolic syndrome inmales in Chengdu[J]. Medical Journal of West China,2019,31(10):1586-1590.
[3] PONTOIZEAU C, GIRARD A, MESBAH H, et al.Prognostic value of baseline total metabolic tumorvolume measured on FDG PET in patients with richtersyndrome[J]. Clinical Nuclear Medicine, 2020, 45(2):118-122.
[4] 毛维维 , 伊桂叶 . 不同肥胖类型患者血清代谢指标与内脏脂肪指数的相关性分析 [J]. 现代检验医学杂志 ,2019,34(5):1-3, 8.MAO Weiwei,YI Guiye. Correlation between serummetabolic indexes of different obesity types and visceraladiposity index[J]. Journal of Modern LaboratoryMedicine ,2019,34(5):1-3, 8.
[5] 朱意平,李春阳,陈超,等.生活方式干预对双相障碍合并代谢综合征患者的影响 [J].齐鲁护理杂志 ,2019,25(1):40-43.ZHU Yiping, LI Chunyang,CHEN Chao, et al. Effect oflifestyle intervention on patients with bipolar disordercomplicated with metabolic syndrome[J]. Journal ofQilu Nursing,2019,25(1):40-43.
[6] 刘珂华 , 刘启贵 , 陈芳芳 , 等 . 代谢综合征与危险因素的相关研究论文可视化分析 [J]. 现代预防医学 ,2019,46(1):180-186.LIU Kehua, LIU Qigui, CHEN Fangfang, et al.Visualization analysis of the studies on metabolicsyndrome and risk factors[J]. Modern PreventiveMedicine ,2019,46(1):180-186.
[7] 郑祎扬,刘怡娅.贵州省成年居民膳食模式与代谢综合征的关系 [J].现代预防医学 , 2019,46(10):1761-1764.ZHENG Weiyang, LIU Yiya. Relationship betweendietary patterns and metabolic syndrome among adultresidents in Guizhou province[J]. Modern PreventiveMedicine, 2019,46(10):1761-1764.
[8] 梁宝璐,陶丽新,陈硕,等.北京市上班族通勤方式与代谢综合征关联性研究 [J].现代预防医学,2019, 46(11):1956-1960.LIANG Baoli, TAO Lixin, CHEN Shuo, et al. Asso-ciation between mode of transportation and metabolicsyndrome of officer workers, Beijing[J]. Modern Pre-ventive Medicine , 2019,46(11): 1956-1960.
[9] 李爽境,黄闪闪,刘熹润,等.决策树模型与logistic 回归模型在代谢综合征影响因素分析中的应用 - 以凉山地区为例 [J]. 现代预防医学,2019,46(13):2319-2323,2328.LI Shuangjing, HUANG Shanshan,LIU Xirun, et al.Application of decision tree and logistic regressionmodel on risk factors of metabolic syndrome: a casestudy in Liangshan region[J].Modern Preventive Medi-cine, 2019, 46(13): 2319-2323,2328.
[10] JIALAL G, ADAMS-HUET B, JIALAL I. Both theplatelet count and the platelet:lymphocyte ratio are notincreased in nascent metabolic syndrome[J]. Platelets,2019, 30(8): 1057-1058.
[11] 王兆秀 , 季红 , 张立瑶 , 等 . 信息平台在代谢综合征病人健康管理中的应用进展 [J]. 护理研究,2019,33(7):1162-1166.WANG Zhaoxiu, JI Hong, ZHANG Liyao, et al.Application progress on information platform in healthmanagement of patients with metabolic syndrome[J].Chinese Nursing Research, 2019,33(7):1162-1166.
[12] 马晓天 , 顾建华 , 王丽 , 等 . 血小板计数与代谢综合征关联性的前瞻性队列研究 [J]. 山东大学学报(医学版), 2018, 56(12):92-97.MA Xiaotian, GU Jianhua, WANG Li, et al. Associationbetween platelet count and metabolic syndrome basedon a prospective cohort study[J]. Journal of ShandongUniversity (Health Science), 2018,56(12):92-97.
[13] 郭海健,念馨,梁友芳,等.基于多中心横断面调查的中国人群代谢综合征的流行情况及危险因素[J]. 中华疾病控制杂志 ,2019,23(7):796-801.GUO Haijian, NIAN Xin, LIANG Youfang, et al. Theprevalence and risk factors of metabolic syndrome inChinese population based on the multi center cross-sectional survey[J]. Chinese Journal of Disease Control& Prevention,2019,23(7):796-801.
[14] 王绵,张力辉,苏胜偶.2018 年内分泌代谢疾病重要临床进展 [J]. 临床荟萃 ,2019,34(1):33-40.WANG Mian, ZHANG Lihui, SU Shengou. Clinicaladvances in endocrine and metabolic disease in 2018[J].Clinical Focus ,2019,34(1):33-40.
[15] 杨滢,王素华,石玉荣.代谢综合征患者 FGF21 水平与HDL亚类分布的关系[J].齐齐哈尔医学院学报,2019, 40(7):793-797.YANG Ying, WANG Suhua, SHI Yurong. The rela-tionship between the distribution of HDL subclass andthe level of serum FGF21 in patients with metabolicsyndrome[J]. Journal of Qiqihar University of Medi-cine,2019, 40(7):793-797.
相似文献/References:
[1]王继贵.基质金属蛋白酶和代谢综合征的研究进展[J].现代检验医学杂志,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
WANG Ji-gui.Progress of Research on Matrix Metalloproteinases and Metabolic Syndrome[J].Journal of Modern Laboratory Medicine,2015,30(06):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
[2]李 艳,李新宇.妊娠糖尿病患者外周血miRNA-21 检测的临床应用价值[J].现代检验医学杂志,2020,35(02):35.[doi:10.3969/j.issn.1671-7414.2020.02.011]
LI Yan,LI Xin-yu.Clinical Application Value of Detection of miRNA-21 in Peripheral Blood ofPatients with Gestational Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(06):35.[doi:10.3969/j.issn.1671-7414.2020.02.011]
[3]廖衍强.糖尿病并发高血压患者血清Cys C 与P 物质水平之间的关系研究[J].现代检验医学杂志,2020,35(02):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
LIAO Yan-qiang.Relationship between Serum Cys C and Substance P Levels in Patientswith Diabetes Mellitus Complicated with Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(06):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
[4]王琳琳a,张晓凝,王刚b,等.外周血白细胞参数对于新型冠状病毒肺炎诊断的临床意义[J].现代检验医学杂志,2020,35(05):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]
WANG Lin-lina,ZHANG Xiao-ning,WANG Gangb,et al.Clinical Significance of Peripheral Blood Leukocyte Parameters in the
Diagnosis of COVID-19[J].Journal of Modern Laboratory Medicine,2020,35(06):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]